Asymchem Laboratories Tianjin Co (HKSE:06821) Marketable Securities : HK$2,155 Mil (As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Asymchem Laboratories Tianjin Co Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Asymchem Laboratories Tianjin Co's Marketable Securities for the quarter that ended in Sep. 2024 was HK$2,155 Mil.

Asymchem Laboratories Tianjin Co's annual Marketable Securities increased from Dec. 2021 (HK$491 Mil) to Dec. 2022 (HK$2,402 Mil) but then declined from Dec. 2022 (HK$2,402 Mil) to Dec. 2023 (HK$2,085 Mil).

Asymchem Laboratories Tianjin Co Marketable Securities Historical Data

The historical data trend for Asymchem Laboratories Tianjin Co's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Asymchem Laboratories Tianjin Co Marketable Securities Chart

Asymchem Laboratories Tianjin Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Marketable Securities

Get a 7-Day Free Trial

491.25

2,402.12

2,084.50

Asymchem Laboratories Tianjin Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Marketable Securities	Get a 7-Day Free Trial															2,258.14	2,084.50	1,558.60	2,196.93	2,154.52

Asymchem Laboratories Tianjin Co Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Asymchem Laboratories Tianjin Co (HKSE:06821) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Asymchem Laboratories Tianjin Co Marketable Securities Related Terms

Thank you for viewing the detailed overview of Asymchem Laboratories Tianjin Co's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Asymchem Laboratories Tianjin Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Asymchem Laboratories Tianjin Co Ltd (HKSE:06821) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

7K90:Germany 002821:China

Address

No. 6 Dongting Third Street, Economic and Technological Development Zone, Tianjin, CHN, 300457

Website

https://www.asymchem.com

Asymchem Laboratories Tianjin Co Ltd is a China-based company, a technology-driven provider of Contract Development manufacturing organization solutions throughout the drug development and manufacturing process. The Group provides clinical-stage CDMO solutions, commercial-stage CDMO solutions, and emerging services. Its operations relate to contract development and manufacturing which focuses on innovation and commercial application of pharmaceutical technology. It has geographic areas in the Chinese Mainland and Overseas.

Executives

Jpmorgan Chase & Co.	2201 Interest of corporation controlled by you
Schroders Plc	2102 Investment manager
Norges Bank	2101 Beneficial owner
Fmr Llc	2201 Interest of corporation controlled by you
Fidelity Investment Trust	2101 Beneficial owner
Springhill Fund Asset Management (hk) Company Limited	2102 Investment manager
Springhill Fund Limited	2201 Interest of corporation controlled by you
Springhill Global Feeder Fund Limited	2201 Interest of corporation controlled by you
Springhill Master Fund Limited	2101 Beneficial owner
Morgan Stanley	2201 Interest of corporation controlled by you
Hhlr Advisors, Ltd.	2102 Investment manager
Hhlr Fund, L.p.	2101 Beneficial owner
Jpmorgan Asset Management (asia Pacific) Limited	2102 Investment manager
Fidelity Management & Research Company Llc

Asymchem Laboratories Tianjin Co Headlines

No Headlines